Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe

被引:81
作者
Towner, K. J. [1 ]
Levi, K. [1 ]
Vlassiadi, M. [1 ]
机构
[1] Univ Nottingham Hosp NHS Trust, Queens Med Ctr, Dept Clin Microbiol, Nottingham NG7 2UH, England
基金
英国医学研究理事会;
关键词
Acinetobacter baumannii; carbapenem resistance; epidemiology; Europe; sequence groups; typing;
D O I
10.1111/j.1469-0691.2007.01911.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In total, 96 carbapenem-resistant isolates of Acinetobacter baumannii were obtained from 25 hospitals in 17 European countries. Imipenem MICs ranged from < 4 to 128 mg/L on retesting by Etest, with MICs >= 16 mg/L being associated with the carriage of genes encoding at least one other class D carbapenemase in addition to the intrinsic OXA-51-like enzyme. Molecular typing results obtained by random amplified polymorphic DNA analysis, followed by pulsed-field gel electrophoresis (PFGE) of ApaI-digested chromosomal DNA, were highly congruent, with 17 different PFGE types being delineated at a cut-off similarity level of 85%. With few exceptions, multiple isolates from a single hospital belonged to the same PFGE type. Seven sequence groups were identified among the 96 A. baumannii isolates, with the majority of isolates (n = 81) belonging to the previously defined sequence groups 1 and 2, which each included eight PFGE types. These two multinational lineages included the previously defined European clones II and I, respectively, but the problem of resistant A. baumannii in Europe appeared not to be confined solely to these two European clones. Rather, two broader lineages of carbapenem-resistant A. baumannii now seem to be spreading throughout Europe.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 28 条
[1]  
[Anonymous], [No title captured]
[2]   PULSED-FIELD GEL-ELECTROPHORESIS AS A REPLACEMENT FOR BACTERIOPHAGE-TYPING OF STAPHYLOCOCCUS-AUREUS [J].
BANNERMAN, TL ;
HANCOCK, GA ;
TENOVER, FC ;
MILLER, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :551-555
[3]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[4]   Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula [J].
Da Silva, GJ ;
Quinteira, S ;
Bértolo, E ;
Sousa, JC ;
Gallego, L ;
Duarte, A ;
Peixe, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :255-258
[5]   Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods [J].
Dijkshoorn, L ;
Aucken, H ;
GernerSmidt, P ;
Janssen, P ;
Kaufmann, ME ;
Garaizar, J ;
Ursing, J ;
Pitt, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (06) :1519-1525
[6]   Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital [J].
Dobrewski, R. ;
Savov, E. ;
Bernards, A. T. ;
van den Barselaar, M. ;
Nordmann, P. ;
van den Broek, P. J. ;
Dijkshoorn, L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (11) :1135-1137
[7]   Acinetobacter species identification by using tRNA spacer fingerprinting [J].
Ehrenstein, B ;
Bernards, AT ;
Dijkshoorn, L ;
GernerSmidt, P ;
Towner, KJ ;
Bouvet, PJM ;
Daschner, FD ;
Grundmann, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) :2414-2420
[8]   The changing global epidemiology of Acinetobacter baumannii infections:: a development with major public health implications [J].
Falagas, M. E. ;
Karveli, E. A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (02) :117-119
[9]   Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. [J].
Grundmann, HJ ;
Towner, KJ ;
Dijkshoorn, L ;
GernerSmidt, P ;
Maher, M ;
Seifert, H ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3071-3077
[10]   Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Fournier, PE ;
Claverie, JM ;
Raoult, D ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) :4174-4179